Opens in a new tab or window A small panel of circulating biomarkers may reliably distinguish hypertrophic cardiomyopathy ... as well as a 12-lead ECG. The initial comprehensive HCM evaluation ...
Cardiac MRI should be a standard assessment for apical hypertrophic cardiomyopathy (HCM) in athletes with a markedly abnormal ECG, specifically an ECG with deep (>−0.2 mV) TWI and ST segment ...
BACKGROUND: Patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction commonly experience ...
Hosted on MSN8mon
Vest can detect earlier signs of heart muscle diseasewhich collects far more detailed electrical signal data than a routine ECG, could support better identification of high-risk patients with hypertrophic cardiomyopathy. Some people living with ...
Objective Current guidelines recommend precautionary disqualification from competitive sports in patients with hypertrophic cardiomyopathy (HCM ... gender balance, symptoms, ECG abnormalities, extent ...
Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...
Technologies announced that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk ...
Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...
may create a diagnostic overlap with pathological conditions such as hypertrophic cardiomyopathy. Furthermore, much interest has focused recently on the possibility of irreversible cardiac ...
A study has found that aficamten is associated with improvements across a range of clinical outcomes in patients with obstructive hypertrophic cardiomyopathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback